Microbiology News : clinical, Aug 2020

RNA Extraction Buccal Swab Porvair COVID SARS
The Chromatrap® Homogeniser Spin Column from Porvair Sciences has been adapted for COVID-19 to ensure an improved yield and quality of viral RNA from nasal and throat swab samples.  more...
COVID SARS Antigen Rapid ABBOTT FDA EUA
Abbott's new antigen test to detect an active infection of SARS-CoV-2 in patients has been granted an FDA-EUA. Abbott claim the test has shown excellent diagnostic accuracy in studies and is very affordable at just $5 per test. A digital health pass (QR code) is available as standard.  more...
SARS influenza RSV CE Primer Genesig Novacyt
The genesig® Winterplex Test panel can distinguish between SARS-CoV-2, Influenza A & B and RSV, requiring just one sample from the patient. Primerdesign's original SARS-CoV-2 assay was one of the first to be recommended by WHO to detect the virus.  more...
sepsis ast mic rapid drast antibiotic quantamatrix
Quantamatrix's dRAST™ platforms are now in 12 European hospital labs and private lab chains. dRAST platform offers Rapid Phenotypic MIC results interpreted in as little as four hours, enabling antibiotic therapy to be adapted for optimal patient and hospital use. more...
transport media for viruses
Make sure you have adequate stocks of swabs and transport media for viruses to ensure your COVID-19 testing service continues without disruption even when flu season starts. Vectornate USA has supplies ready to ship worldwide. more...
This weeks COVID 19 Updates
Check out this week's COVID-19 updates: A saliva test for COVID-19, a new workflow for detecting SARS-CoV-2 in food processing environments, rapidmicrobiology's new reagents resource for COVID-19 kit & therapy developers, report on lateral flow tests and a MALDI-TOF COVID-19 test! more...
Yale University has been granted EUA from the US FDA for its SalivaDirect COVID-19 testing protocol. The method is seen as a game-changer by many, as it avoids the use of reagents prone to global shortages and is a non-invasive technique, requiring only a saliva specimen.  more...
nox 18 SY Lab easiest high sample anaerobic jar
Small footprint – high sample capacity - nox.18 - the new square jar - making anaerobic incubation much simpler! more...
BD Kiestra InoquIA Synapsys
The BD Kiestra™ InoqulA system is now available in Europe. This automated standalone microbiology workflow allows users to switch seamlessly between two modes to process liquid and non-liquid samples, and with the BD Synapsys™ informatics solution provides complete traceability.  more...
Ethos COVID SARS 2 MALDI TOF RT PCR
Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay has received FDA-EUA. The test utilizes both RT-PCR and ionization technology for the qualitative detection of viral RNA from a swab sample. The test is also authorized to take samples from Ethos At-home-Collection-kit.  more...
biofire filmarray luminex xTAG gastrointestinal
Luminex xTAG Gastrointestinal Pathogen Panel (GPP) and bioMérieux’s BIOFIRE® FilmArray Gastrointestinal Panel have undergone performance evaluation by the US-China Program in Emerging and Re-Emerging Infectious Diseases with the publication of results.   more...
UK Antibody IgG COVID 19
The UK Government has published a peer-reviewed study on lateral-flow immunoassay (LFIA) COVID-19 kits that detect IgG only. LFIA were shown to have inferior sensitivity to ELISA but had high specificity, and were shown to be used competently by general public.  more...
WHO COVID 19 survey
The World Health Organization has drafted new criteria on high volume and near-patient antibody and viral detection COVID-19 assays. The purpose of which is to improve its assessment of test kits on a case-by-case basis. Deadline for comments is 19 August.  more...
This weeks COVID 19 Updates
Check out this week's COVID-19 updates including viral RNA extraction, serology IgG testing, qPCR, VTM and more... more...
Eurofins viracor pooled covid testing pcr
Eurofins adds qPCR COVID-19 pooled testing to its SAFER@WORK™ programme: designed to help companies set up advanced risk management protocols to contribute to limiting the impact of COVID-19 in the workplace. An FDA-EUA application is in process, and testing is scheduled across the US. more...
siemens cov2g IgG semi quantitative FDA EUA
Siemens Healthineers has received FDA Emergency Use Authorization (EUA) for the SARS-CoV-2 IgG (COV2G) antibody test. It's the first semi-quantitative test offering sensitivity and specificity over 99% and enables clinicians to gauge levels of IgG in patient's blood sample.  more...
ViroStat has developed and released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final 5 antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen. more...
Quest COVID 19 Viral RNA extraction
Quest Diagnostics has received FDA-EUA for a new viral RNA extraction technique that will increase its testing capacity to 185,000 per day. The method extracts RNA with the Mag-Bind Viral RNA Xpress Kit (Omega Bio-Tek) and the Hamilton MagEx STAR. more...
Perkin Elmer dried blood spot covid 19 gsp delfia igG
Perkin Elmer has launched a dried blood spot test for COVID-19 serology IgG testing. The finger-prick sample collection device allows for both decentralized sample collection and high-throughput testing. The product is CE-IVD marked and planned for US FDA-EUA. more...
Thermo Fisher COVID 19 Amplitude
Thermo Fisher Scientific has introduced a new highly-automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day. The modular solution delivers test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources. more...
Vacusafe Aspiration System
Laboratories can achieve stringent biosafety level guidelines, for handling contaminated solutions, using INTEGRA’S VACUSAFE system. more...
Viral Transport Medium
Liofilchem VTM is suitable for the collection and preservation of clinical specimens containing viruses, including SARS-CoV-2 (COVID-19), Chlamydia spp., Mycoplasma spp. and Ureaplasma spp. more...
RUO COVID-19 ELISA for Vaccine Developers
COVID-SeroIndex test kit is an ELISA assay, designed to measure the presence or absence of anti-COVID-19 antibodies in addition to measuring the titer of antibodies a person has produced.  It utilizes not one, but two virus antigens: the full-length spike protein, and its receptor binding domain. more...
COVID-19 LIMS solution
The COVID-specific LIMS solution incorporates LabVantage’s deep knowledge of laboratory workflows, along with numerous features designed to make it easy for laboratories to perform coronavirus testing using RT-PCR, isothermal nucleic acid amplification, and serology methods. more...
This weeks COVID 19 Updates
Here you will find a round-up of the latest updates in COVID-19 diagnostics, testing kits, qPCR and intrumentation. more...
COVID-19 Diagnostics for Non-Lab Settings
The FDA has posted a new template for commercial developers to help them submit EUA requests for COVID-19 diagnostic tests that can be performed entirely at home or in other settings besides a lab, such as offices or schools, and that could be available without a prescription. more...
LamPORE SARSCoV2 assays
LamPORE is a precise, rapid, low-cost and highly scalable assay for the detection of SARS-CoV-2, designed to test saliva and swab RNA samples from either symptomatic or asymptomatic people. Using RT-LAMP to amplify specific viruses and nanopore sequencing to identify the amplified viruses. more...
BSL3 Virology Testing Service
With new virology services capabilities, Microbiologics has launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies. more...
The test, shown in CRL's EUA studies to be more sensitive and accurate than the standard COVID-19 anterior nasal swab test, detects the presence of coronavirus in the saliva of the test taker. more...
The xMAP SARS-CoV-2 Multi-Antigen IgG Assay demonstrated specificity of 100 percent in human serum and greater than 99 percent in human plasma, with sensitivity greater than 96 percent for both human serum and plasma (>14 days post-symptom onset) in clinical studies. more...